Seres Therapeutics (MCRB) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-3.93
-1.37
1.19
3.75

Details

Expected EPS
0.102028
Actual EPS
3.75
Surprise EPS
3.65
Surprise Percent
+3,575.46%

Description

Seres Therapeutics (MCRB) has reported earnings of 3.75 per share for Q2 2025.

0 Comments

Share your thoughts